北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学临床肿瘤学院  > 期刊论文
学科主题: 临床医学
题名:
A 3-DAY ORAL APREPITANT REGIMEN PROVIDES SUPERIOR PREVENTION OF CINV OVER STANDARD THERAPY IN CHINESE PATIENTS RECEIVING HIGH-DOSE CISPLATIN
作者: Zhang, Li1; Cheng, Ying2; Zhang, Hong-Yu3; Zhou, Caicun4; Han, Baohui5; Zhang, Yiping6; Huang, Cheng7; Chang, Jianhua8; Song, Xiang Q.9; Liang, Jun10; Liang, Houjie11; Bai, Chunxue12; Yu, Shiying13; Chen, Jia14; Wang, Jie15; Pan, Hongming16; Carides, Alexandra17; Chitkara, Denesh17
关键词: high-dose cisplatin ; Aprepitant ; CINV
刊名: JOURNAL OF THORACIC ONCOLOGY
发表日期: 2011-06-01
卷: suppl.2, 期:6, 页:S458-S459
收录类别: SCI
文章类型: Meeting Abstract
WOS标题词: Science & Technology
类目[WOS]: Oncology ; Respiratory System
研究领域[WOS]: Oncology ; Respiratory System
语种: 英语
WOS记录号: WOS:000208855802185
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/52500
Appears in Collections:北京大学临床肿瘤学院_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.Canc Hosp Fujian, Dept Med, Fuzhou, Fujian, Peoples R China
2.Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China
3.Fudan Univ, Zhongshan Hosp, Shanghai, Peoples R China
4.Tongji Hosp, Wuhan, Hubei, Peoples R China
5.Jiangsu Canc Hosp, Nanjing, Jiangsu, Peoples R China
6.Sir Run Run Shaw Hosp, Hangzhou, Zhejiang, Peoples R China
7.Merck & Co Inc, Whitehouse Stn, NJ USA
8.Jilin Prov Canc Hosp, Changchun, Peoples R China
9.Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China
10.Sun Yat Sen Univ, Ctr Canc, Guangzhou, Guangdong, Peoples R China
11.Sun Yat Sen Univ, Hosp Affiliated 5, Guangzhou, Guangdong, Peoples R China
12.Tongji Univ, Affiliated Shanghai Pulm Hosp, Shanghai, Peoples R China
13.Shanghai Jiao Tong Univ, Affiliated Shanghai Chest Hosp, Shanghai 200030, Peoples R China
14.Guangxi Med Univ, Affiliated Tumor Hosp, Nanning, Peoples R China
15.Qingdao Univ, Affiliated Hosp, Qingdao, Shandong, Peoples R China
16.Third Mil Med Univ, Southwest Hosp, Chongqing, Peoples R China
17.Peking Univ, Sch Oncol, Beijing Canc Hosp, Beijing, Peoples R China

Recommended Citation:
Zhang, Li,Cheng, Ying,Zhang, Hong-Yu,et al. A 3-DAY ORAL APREPITANT REGIMEN PROVIDES SUPERIOR PREVENTION OF CINV OVER STANDARD THERAPY IN CHINESE PATIENTS RECEIVING HIGH-DOSE CISPLATIN[J]. JOURNAL OF THORACIC ONCOLOGY,2011,suppl.2(6):S458-S459.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Zhang, Li]'s Articles
[Cheng, Ying]'s Articles
[Zhang, Hong-Yu]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Zhang, Li]‘s Articles
[Cheng, Ying]‘s Articles
[Zhang, Hong-Yu]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace